Imricor Medical Systems today said it won CE mark approval for its Vision-MR Ablation Catheter and Vision-MR Dispersive Electrode. “We are absolutely thrilled to bring to market our products for performing cardiac catheter ablations guided by real-time MRI,” chairman and CEO Steve Wedan said in a news release. “Receipt of CE mark approval marks a […]
Imricor raises $2m
Imricor Medical Systems has raised $1.5 million in a new round of debt and securities financing, according to an SEC filing posted this week. Money in the funding round came from 19 unnamed investors, with the date of the first sale reported on April 4, 2018. The company is not looking to raise any more money […]
HRS 2018 Roundup: Device-related blood clots with Boston Scientific’s Watchman implant
Data from a study of device-related blood clots and the Watchman cardiac implant made by Boston Scientific (NYSE:BSX), presented today at the annual meeting of the Heart Rhythm Society in Boston, indicate the need for aggressive management of patients at risk for device-related thrombosis. There were 74 incidences of DRT in 65 of the 1,739 Watchman […]
Imricor wins CE Mark for MR-conditional recording system
Imricor Medical Systems said today it won CE Mark approval in the European Union for its Advantage-MR EP recorder/stimulator system, designed to allow for MRI-guided electrophysiology procedures. The system, along with MR-compatible ablation catheters, will allow operating physicians to perform cardiac ablations using real-time MRI guidance, which the Minneapolis, Minn.-based company said could improve safety […]
Imricor Medical drums up $3 million
By Thomas Lee
BURNSVILLE, Minnesota– Imricor Medical Systems Inc. raised $3.1 million, according to a filing with the federal Securities and Exchange Commission.
Working with General Electric (NYSE:GE), a major maker of MRI machines, Imricor is developing an MRI-guided catheter system to treat cardiac arrhythmias like atrial fibrillation.
